Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...
Solutions Market growth is driven by rising hospitalization rates, increasing prevalence of chronic diseases, expanding surgical volumes, and growing demand for parenteral nutrition and fluid ...
Tiruchy: In a case highlighting alleged medical negligence, a contractual nurse at Thanjavur Medical College Hospital has ...
Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP(TM) (Mercury ...
Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed immunochemotherapy across ongoing SCLC and NSCLC trials; enrollment ...
While influenza remains the top concern for Maine public health experts, other viruses are also currently circulating, ...
As of Friday, January 09, Heron Therapeutics, Inc.’s HRTX share price has surged by 10.63%, which has investors questioning ...
2don MSN
A CT hospital is expanding a program that is saving lives. Here’s how it works, why it was adopted
Use of whole blood products to save egregiously injured U.S. military combatants became a practice during wars in Iraq and ...
Positive full results from AstraZeneca’s Phase III TULIP-SC trial have shown the subcutaneous (SC) administration of Saphnelo ...
New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding ...
Paolo Ferrigno Product Manager prefilled syringes and cartridges Datwyler Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback